Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Dorsal (top) and ventral (side) view of a human embryo approx. 16 – 19 days after fertilisation. The embryonic disk (left) ultimately gives rise to the fetus. The embryo is undergoing a process called gastrulation, whereby different cell types are generated and distributed to specific places in the embryo.

Due to more readily available samples, studies so far have focused on the first week after conception and at later stages beyond a month into pregnancy, during which organs form and mature. However, there is currently very little understanding of events that take place in the intervening days, which includes the crucial gastrulation stage that occurs shortly after the embryo implants in the womb. Analysis of a unique sample by researchers from DPAG and Helmholtz Zentrum München helps fill the gap in our knowledge of early human embryogenesis. Their findings, published in the journal Nature, will contribute to the improvement of experimental stem cell models.

Gastrulation is one of the most critical steps of development, and takes place roughly between days 14 and 21 after fertilization.  A single-layered embryo is transformed into a multi-layered structure known as the gastrula. During this stage, the three main cell layers that will later give rise to the human body’s tissues, organs and systems are formed. Principal Investigator Professor Shankar Srinivas said: “Our body is made up of hundreds of types of cells. It is at this stage that the foundation is laid for generating the huge variety of cells in our body – it’s like an explosion of diversity of cell types.”  

The study is a milestone for developmental biology as ethically obtained human samples at these early stages are exceptionally rare. The collaborative research team obtained the sample through the Human Developmental Biology Resource, from an anonymous donor who generously provided informed consent for the research use of embryonic material arising from the termination of her pregnancy. The sample is estimated to be from around 16 – 19 days after fertilisation. Lead researcher Dr Richard Tyser said: “This is such an early stage of development that many people would not have known they were pregnant. It is the first time an embryo at this stage of development has been characterised in such detail using modern technology.”  

To better understand human development or develop treatments for injury or disease, scientists experiment with human stem cells in the laboratory. Professor Srinivas said: “If you want to make a stem cell into, say, a heart cell, the best way is to learn how it happens in nature and recreate that in the lab. But if you don’t know what happens in nature, then you essentially have to guess.” This study is valuable because it offers a unique glimpse into a central but inaccessible stage of our development.

Researchers can only legally culture human embryos up to the equivalent of 14 days of development, which is just before the start of gastrulation, so it is not currently possible to study this stage in cultured human embryos. Consequently, our knowledge of events beyond 14 days after fertilization is largely based on studies in animal models such as mouse and chicken. Dr Tyser said: “Our new sample is the bridge that links the very early stage of development with the later stages when organs begin to form. This link in the human had previously been a black box , so we had to rely on other model organisms such as the mouse. Reassuringly, we have now been able to show that the mouse does model how a human develops at the molecular level. Such models were already providing valuable insights, but now this research can be further enriched by the fact we’re able to cast light into that black box and more closely see how it works in humans.”

Using the powerful technique of single cell sequencing to closely profile the embryo’s individual cells, researchers were able to identify 11 distinct cell types. While most of these cells were still immature, they discovered the presence of both blood cells and the primordial germ cells that give rise to gametes (ovum and sperm cells). Notably, the team did not find any evidence of mature neuronal cells or other cell types associated with the central nervous system. This study detailing the types of cells in the gastrula could inform an ongoing debate in the scientific community around reconsidering the ‘14-day rule’, which sets a limit to culturing intact human embryos.

As part of the University of Oxford’s commitment to open research, the team made the raw data available to researchers around the world prior to publication. Professor Srinivas said: “Many people have already requested our molecular data and used it in their own analyses. The images of the embryo are also really valuable and have attracted a lot of interest because they are amongst the clearest images of this particular stage of development.” To further make this valuable information accessible, the team created an interactive website for both the science community and general public. Dr Tyser said: “We’ve made it very easy for people to access this data, so anybody can go and look at a gene of interest and see where it's expressed in the human embryo at this stage.”

The full paper, "Single-cell transcriptomic characterization of a gastrulating human embryo" is available to read in Nature.

View the Human Gastrulation Data website.

This story is also covered on the University of Oxford website.

Similar stories

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

New Pfizer grant paves the way to a better understanding of how body fat is controlled

Professor Ana Domingos has been awarded a highly competitive independent research grant from Pfizer to discover ‘the role of Sympathetic-associated Perineurial barrier Cells in obesity’.